Skip to content

HIV prevention: does scaring people work?

From Kenya to Kennington

Towards a cure for all (part one)

A winter of discontent?

Warning issued to Fuzeon, Pegasys, Viraferon Peg and Intron A users

Little evidence of transmission of virus that's resistant to newer anti-HIV drugs

Bone loss a general side-effect of HIV therapy, suggests small study

Treatment interruptions explain higher HIV viral load in patients with depression and those who use stimulants

Atazanavir dose adjustment in pregnancy approved by US FDA